ASMB Earnings

Quarterly EPS
$-1.51
Q3 2024
$-1.58
Q4 2024
$-1.17
Q1 2025
$-1.33
Q2 2025
$-0.72
Q3 2025
$1.30
Q4 2025
$-0.54
Q1 2026
$-0.20
Q2 2026
Latest Revenue13.4M
Latest Net Income-3857000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.2013.4M-3857000+38.9%+85.0%
Q1 2026-$0.548.2M-9079000-12.8%+53.8%
Q4 2025$1.3042.5M22.1M+477.3%+182.3%
Q3 2025-$0.7210.8M-9196000+57.6%+52.3%
Q2 2025-$1.339.6M-10198000+12.8%+32.8%
Q1 2025-$1.179.4M-8818000+62.8%+29.5%
Q4 2024-$1.587.4M-10335000+2.7%+23.3%
Q3 2024-$1.516.8M-9613000+54.1%
Q2 2024-$1.988.5M-11152000
Q1 2024-$1.665.8M-9077000
Q4 2023-$2.067.2M-10962000
Q3 2023-$3.290-14420000
Assembly Biosciences (ASMB) — Earnings